These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1349746)

  • 41. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 Jun; 36(2):339-44. PubMed ID: 2141423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
    Nevins ME; Anthony EW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of effects of 5-HT3 antagonists on normal and morphine-attenuated sexual behaviours in female and male rats.
    Tanco SA; Watson NV; Gorzalka BB
    Experientia; 1993 Mar; 49(3):238-41. PubMed ID: 8458409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.
    Bill DJ; Fletcher A; Glenn BD; Knight M
    Eur J Pharmacol; 1992 Aug; 218(2-3):327-34. PubMed ID: 1358637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serotonin receptor subtype anxiolytic agent].
    Zhang ZQ
    Sheng Li Ke Xue Jin Zhan; 1993 Oct; 24(4):358-60. PubMed ID: 7911252
    [No Abstract]   [Full Text] [Related]  

  • 55. Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.
    Takahashi RN; Berton O; Mormède P; Chaouloff F
    Braz J Med Biol Res; 2001 May; 34(5):675-82. PubMed ID: 11323756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An anxiolytic-like effect of ondansetron disappears in oxazepam-tolerant rats.
    Nowakowska E; Chodera A; Kus K
    Pharmacol Biochem Behav; 1998 Apr; 59(4):935-8. PubMed ID: 9586851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of 5-HT receptor ligands on ultrasonic calling in mouse pups.
    Nastiti K; Benton D; Brain PF; Haug M
    Neurosci Biobehav Rev; 1991; 15(4):483-7. PubMed ID: 1686487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data.
    Wesołowska A
    Pharmacol Rep; 2010; 62(4):564-77. PubMed ID: 20884998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin antagonists induce anxiolytic and anxiogenic-like behavior in zebrafish in a receptor-subtype dependent manner.
    Nowicki M; Tran S; Muraleetharan A; Markovic S; Gerlai R
    Pharmacol Biochem Behav; 2014 Nov; 126():170-80. PubMed ID: 25284132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 May; 420(2-3):113-7. PubMed ID: 11408032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.